
Vertanical’s Phase 3 win for non-opioid painkiller; Apriori lays off 40% of staff
Plus, news about Pillar, vTv Therapeutics, OPKO Health, Entera Bio, Zentalis, Sutro Biopharma and Idorsia:
Vertanical’s non-opioid painkiller succeeds in Phase 3: The German biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.